Debating Genomic Medicine | GenomeWeb

If whole-genome sequencing ever becomes a common part of treating patients, as is expected by many, some tricky ethical and privacy-related problems may arise, most notably questions about what should be done about incidental findings and malevolent things doctors find in the genome that have no treatment.

At Washington University in St. Louis this week, at a global center of genomic medicine, a few experts met in a panel discussion to sift around a bit through the morass of ethical questions whole-genome sequencing might stir up when it does hit the clinic.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Related Posts

BRCA in the Family

At a Cost

Spot for Information

In Science this week: global genetic diversity map, and more.

The Nuffield Council on Bioethics identifies ethical questions to explore surrounding genome editing.

In a blog post, Brigham and Women's Hospital's Robert Green discusses "predispositional personal genome sequencing."

Stat News reports that there's muted opposition to the Kuwaiti DNA database law.